Recent Grants Awarded

ACODEV: Action for Community Development


ACODEV was awarded a two-year, $80,000 grant for the project, Institutionalizing Proven Approaches to Reduce Maternal, Newborn and Child Mortality in Luwero district of Central Uganda.

The project will implement innovations at Level III of the Healthcare system with five Health Center IIIs to improve the supply of quality MNCH services, to increase demand for services by the beneficiaries, and to enhance an enabling environment that will support sustainability of these proven approaches.

Key activities will include building capacity of Facility Based Health Workers (FBHWs); equipping Health Facilities with the essential maternal and newborn equipment; skilling Health Managers in effective Leadership and Management practices; mentoring and coaching of FBHWs on MNC care standard protocols in emergency obstetrics, family planning, Helping Babies Breath (HBB), maternal infant nutrition among others; facilitating health units supervision; conducting MNCH service audits including death audits; supporting District Health Leadership to improve planning, monitoring and accountability; supporting community MNCH self-help initiatives; facilitate MNCH community champions to promote MNCH positive behaviors; conducting MNCH services outreaches in underserved and hard to reach areas; documenting and disseminating evidence; building local capacity of one district based Civil Society Organizations (CSOs) on MNCH delivery; and supporting institutionalization of a district Maternal Health Task Force.

Overall Goal

The overall goal is to contribute to an accelerated reduction in maternal, newborn and child morbidity and mortality in Luwero District.

Gardens for Health International


Gardens for Health International was awarded a two-year, $100,000 grant for the project, Promoting Nutrition-Focused Agriculture and Comprehensive Health by Strengthening Health Systems in Musanze District, Rwanda.

GHI works in Rwanda to provide lasting agricultural solutions to chronic malnutrition. GHI partners with 18 health centers in 2 districts of Rwanda to integrate agriculture and comprehensive health education into the clinical treatment of malnutrition. GHI works with the Rwandan Ministries of Health and Agriculture and with multinational partners to advocate for policies and programs that include agriculture in the treatment of malnutrition. GHI also provides technical assistance to regional partners interested in adapting their model and methodology for their communities. In Busogo, a sector of Musanze District in northwestern Rwanda, they’re strengthening the partnership with the sector-level health center by continuing the direct programming activities: leading routine malnutrition surveillance, enrolling 240 partners over the next 2 years in 14-week comprehensive, interactive health and agriculture trainings, providing them with Home Garden Packages, and following up with regular home visits. In addition, they’re building the capacity of Musanze District’s health system by training Community Health Workers district-wide on malnutrition surveillance, nutrition-focused agriculture, and intersectional health topics. With continued support from the IZUMI Foundation, the program will touch thousands of people in Busogo in 2017 and 2018, setting them on the path to healthier futures. In addition, the work strengthening the health system of Musanze District will empower hundreds of Community Health Workers with authority and agency around malnutrition, moving the needle on this disease in one of the regions of Rwanda that needs it most.

Overall Goal

The overall goal is  to provide 240 partner families in Busogo with the agricultural inputs, peer-led support, and technical expertise they need to overcome chronic malnutrition in their homes and communities, while simultaneously using chronic malnutrition as an entry point to build the capacity of Busogo Health Center staff, and advocating for the incorporation of agriculture into the clinical treatment of malnutrition across Rwanda.

Last Mile Health


Last Mile Health was awarded a two-year, $100,000 grant for the project, Reproductive, Maternal and Neonatal Health Training for Community Health Workers in Liberia’s Remote Villages.

LMH will implement a cascaded training module for Reproductive, Maternal & Neonatal Health (RMNH) in Gbarpolu and Grand Cape Mount counties of Liberia. LMH will implement the national Community Health Assistant(CHA) program and train  404 Community Health Workers(CHW) and 33 CHW supervisors to serve a remote population of approximately 40,000 people.

Overall Goal

The overall goal is to support direct implementation of the Ministry of Health’s National Community Health Assistant (NCHA) Program in Grand Cape Mount and Gbarpolu counties.

Mano a Mano


Mano a Mano was awarded a three-year, $150,000 grant for the project, Providing Comprehensive Training, Education, & Support to Improve Health in Rural Bolivia.

The project would advance the sustainability of the integrated support programs that complement Mano a Mano’s existing health care infrastructure network: continuing education for medical professionals; constructing greenhouses and other low-cost, low-tech tools, and training farmers to raise more nutritious crops; and providing air transport of health care into tropical areas. These support programs address areas of mutual interest – to improve maternal and infant health, reduce malnutrition, address neglected tropical diseases, and strengthen infrastructure that improves health care—for isolated rural Bolivian communities in the Altiplano and tropical regions of Bolivia. Having a base of funds in place over a 3-year period would allow Mano a Mano to be in a more stable position to provide services, be able to consistently schedule over a longer time period, and provide the opportunity to spend more time assessing and developing the program framework to be able to better meet the needs in Bolivia.

Overall Goal

The overall goal with this project is to be able to consistently provide support programs that complement the existing health systems and infrastructure in Bolivia, in order to improve the health and overall living standards for rural Bolivian communities.



Sightsavers was awarded a two-year, $300,000 grant for the project, Elimination of River Blindness and Lymphatic Filariasis in Liberia.

Sightsavers is working to assist the Government of Liberia Ministry of Health to achieve the elimination of two NTDs, river blindness and lymphatic filariasis, in all 15 counties of Liberia by 2025 and 2019 respectively. These NTDs cause pain and disability, yet are entirely preventable. Sightsavers’ project will support implementation of the WHO recommended mass drug distribution of Mectizan® and albendazole. Mectizan®, developed by Merck & Co Inc. is a highly effective drug approved for mass treatment of river blindness and elephantiasis. The cost-effective intervention approach consists of Mectizan® treatment in river blindness endemic communities and the co-distribution of Mectizan® with albendazole in those communities where both diseases are present. Program activities will include strengthening skills of Liberian health workers and volunteer drug distributors through training, improving data collection on drug distribution to monitor progress and assess impact, distributing treatments to all 15 counties of Liberia and building community awareness and ownership. Across 2017 and 2018 Sightsavers will support the delivery of program activity protecting 3,021,173 people from river blindness and 2,878,414 people from lymphatic filariasis. Following limited program activity in 2014 – 15 due to Ebola, it is now vital that the recently re-started program activities are supported and momentum is kept during 2017 and 2018 to keep Liberia on its path to achieving elimination.

Overall Goal

The overall goal is to contribute towards achieving the elimination of the NTDs river blindness and lymphatic filariasis in Liberia by 2025 and 2019 respectively, through implementation of the WHO recommended mass drug administration (MDA) of Mectizan® and albendazole tablets.